Allergy Diagnostics Market By Test Type (In Vivo, In Vitro), By Product & Service (Consumables, Instruments, Services), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By End-user (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global allergy diagnostic market is envisioned to garner $16,714.2 million by 2031, growing from $4,965.4 million in 2021 at a CAGR of 13.2% from 2022 to 2031.
An allergy is referred to as a systemic sensitivity condition in medical terminology. To assess whether the patient's body is allergic to any known substances, a competent allergy expert will perform an allergy diagnostic test. The diagnosis of allergy is typically made with a diagnostic test or a biopsy.
The main risk factors for developing chronic respiratory disorders are occupational exposure, allergen exposure, and exposure to indoor and outdoor air pollution. Due to the greater exposure to environmental toxins in cities, the prevalence of allergy illnesses is higher among urban residents than rural residents (as a result of vehicular pollution and industrial activities). Although this is a worldwide trend, its impacts are more severe in the metropolitan regions of low-income nations, where more than 80% of people live in locations where air quality levels exceed WHO (World Health Organization) safety guidelines. Given that air pollution from automobiles has been identified as one of the key risk factors contributing to allergic disorders, this is a significant signal for the market growth for allergy diagnostic. Asthma, allergic rhinitis, and other allergy illnesses are more common when there is air pollution, according to epidemiological and toxicological study. Studies have also shown a considerable rise in the prevalence and severity of asthma attacks in metropolitan areas with high concentrations of ozone, nitrogen dioxide, and PM 2.5 (particulate matter having a diameter of 2.5 micrometers or smaller). Members of the allergy and immunology communities have conducted studies that demonstrate how pollutants enhance early and late allergic reactions.
On the other side, it is also anticipated that the rising price of allergy diagnostic equipment would restrain the market expansion over the projected time frame. The shortage of allergists, however, may provide further difficulties for the development of the allergy diagnostic industry in the near future.
The market for allergy diagnostic is predicted to have lucrative opportunities due to the growing adoption of mHealth apps. The use of mHealth for rhinitis diagnosis is currently restricted since there are so few mHealth tools for Allergic Rhinitis (AR) diagnosis that have been published in peer-reviewed publications. Recent developments in integrated biosensors, wireless connectivity, and power harvesting methods have given rise to a new generation of point-of-care gadgets.
Due to the global COVID outbreak, there was a little reduction in the market for allergy diagnostics. Given that affected patients are well-instructed about avoiding potential environmental triggers and treating acute events, also based on written action plans, diagnostic procedures were postponed in the majority of allergic diseases. However, once the pandemic was under control, the diagnostic processes resumed.
The key players profiled in this report include Thermo Fisher Scientific, PerkinElmer Inc., Danaher, Hitachi Chemicals, BIOMÉRIEUX, Omega Diagnostics Group PLC, Siemens, Eurofins Scientific, Stallergenes Greer, and Neogen Corporation
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the allergy diagnostic market analysis from 2021 to 2031 to identify the prevailing allergy diagnostic market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the allergy diagnostic market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global allergy diagnostic market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Test Type
In Vitro
In Vivo
By Product Service
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens
By End-user
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
United Arab Emirates
South Africa
Rest of LAMEA
Key Market Players
Alerchek Inc.
Danaher Corp
Hitachi chemical Diagnostic Inc.
HOB Biotech Group Co. Ltd.
Hycor Biomedical Inc.
Lincoln Diagnostics Inc.
Omega Diagnostic Llc
Siemens Healthcare Diagnostics, Inc.
Stallergenes SA
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Danaher
Omega Diagnostics Group PLC
Eurofins Scientific
bioMérieux SA
HollisterStier Allergy
Minaris Medical America, Inc.
ACON Laboratories, Inc.
Lincoln Diagnostics, Inc.
Neogen Corporation
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook